Please use this identifier to cite or link to this item:
http://localhost:8080/jspui/handle/123456789/1179
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Momin, MD. Abdul | - |
dc.date.accessioned | 2022-11-30T05:54:28Z | - |
dc.date.available | 2022-11-30T05:54:28Z | - |
dc.date.issued | 2009-06 | - |
dc.identifier.uri | http://dspace.cvasu.ac.bd/jspui/handle/123456789/1179 | - |
dc.description.abstract | The study was carried out at Kosba thana in Brahman Baria district in order to investigate the present status of Babesiosis in goat and its response to therapeutics. A total of 31 clinically suspected goats blood sample were collected from ear vein during the study period of 17 December, 2008 to 16 February, 2009. Thin blood smears were prepared immediately after taking the blood samples. The slides were fixed in methanol for 5 min and stained by Giemsa stain. Then examined under high power of magnification (10×100x) by using microscope for the presence of Babesia sp. in RBC. Among them only 1 sample was positive (3.23%). The goat was treated with Diminazene aceturate at 3.5 mg per kg body weight and vitamin B-complex in injectable form along with fluid therapy. The goat was recovered after treatment with Diminazene aceturate and it found effective against goat Babesiosis. | en_US |
dc.description.sponsorship | Department of Pathology and parasitology | en_US |
dc.language.iso | en | en_US |
dc.publisher | Chattogram Veterinary & Animal Sciences University, Khulshi-Chattogram | en_US |
dc.subject | : Babesiosis, goat, percentage, therapeutics. | en_US |
dc.title | OCCURRENCE OF BABESIOSIS IN GOAT AT KOSBA THANA IN BRAHMAN BARIA DISTRICT | en_US |
dc.type | Technical Report | en_US |
Appears in Collections: | Clinical Report |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Front Page.doc | 2.16 MB | Microsoft Word | View/Open | |
momin clinical report 01.doc | 1.39 MB | Microsoft Word | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.